Ketamine Not Yet Recruiting Phase 3 Trials for Analgesia / Vaso-occlusive Crisis / Vaso-Occlusive Pain Episode in Sickle Cell Disease / Intranasal Ketamine / Ketamine / Sickle Cell Disorders Treatment

Not Yet RecruitingTreatment3 IdentifierTitleDrugs
NCT04150757Intranasal Ketamine For Pain Control In Patients With Sickle Cell Disease And Vaso-occlusive Episode (VOE) In The PED
NCT02801292Ketamine as an Adjuvant Therapy for Acute Vaso Occlusive Crisis in Pediatric Patients With Sickle Cell Disease